Pulmatrix, Inc. (PULM)

Pulmatrix Statistics

Total Valuation

Pulmatrix has a market cap or net worth of $4.60 million. The enterprise value is $1.28 million.

Market Cap	4.60M
Enterprise Value	1.28M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Pulmatrix has 3.65 million shares outstanding.

Current Share Class	3.65M
Shares Outstanding	3.65M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	9.18%
Float	3.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.74
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.96

Current Ratio	4.96
Quick Ratio	3.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -84.30% and return on invested capital (ROIC) is -53.71%.

Return on Equity (ROE)	-84.30%
Return on Assets (ROA)	-45.97%
Return on Invested Capital (ROIC)	-53.71%
Return on Capital Employed (ROCE)	-128.49%
Weighted Average Cost of Capital (WACC)	14.92%
Revenue Per Employee	n/a
Profits Per Employee	-$2.26M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.56% in the last 52 weeks. The beta is 1.94, so Pulmatrix's price volatility has been higher than the market average.

Beta (5Y)	1.94
52-Week Price Change	-80.56%
50-Day Moving Average	1.51
200-Day Moving Average	3.33
Relative Strength Index (RSI)	39.58
Average Volume (20 Days)	18,700

Short Selling Information

The latest short interest is 40,413, so 1.11% of the outstanding shares have been sold short.

Short Interest	40,413
Short Previous Month	19,602
Short % of Shares Out	1.11%
Short % of Float	1.11%
Short Ratio (days to cover)	1.13

Income Statement

Revenue	n/a
Gross Profit	-38,000
Operating Income	-4.61M
Pretax Income	-4.53M
Net Income	-4.53M
EBITDA	n/a
EBIT	-4.61M
Earnings Per Share (EPS)	-$1.24

Balance Sheet

The company has $3.32 million in cash and n/a in debt, with a net cash position of $3.32 million or $0.91 per share.

Cash & Cash Equivalents	3.32M
Total Debt	n/a
Net Cash	3.32M
Net Cash Per Share	$0.91
Equity (Book Value)	3.59M
Book Value Per Share	0.72
Working Capital	3.58M

Cash Flow

Operating Cash Flow	-4.69M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	-4.69M
FCF Per Share	-$1.28

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pulmatrix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-98.35%
FCF Yield	-101.85%

Analyst Forecast

The average price target for Pulmatrix is $10.00, which is 693.65% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	693.65%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a